Targeting VCAM-1 resulted in inhibition of early plaque formation in low-density lipoprotein receptor (Ldlr−/−) deficient mice and, thus, plays an important role in early atherosclerosis [16]. This evidence concerns the gene VCAM1 and atherosclerosis.